235 related articles for article (PubMed ID: 17627900)
21. Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans.
Partin MR; Grill J; Noorbaloochi S; Powell AA; Burgess DJ; Vernon SW; Halek K; Griffin JM; van Ryn M; Fisher DA
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):768-76. PubMed ID: 18381474
[TBL] [Abstract][Full Text] [Related]
22. Health care provider-directed intervention to increase colorectal cancer screening among veterans: results of a randomized controlled trial.
Ferreira MR; Dolan NC; Fitzgibbon ML; Davis TC; Gorby N; Ladewski L; Liu D; Rademaker AW; Medio F; Schmitt BP; Bennett CL
J Clin Oncol; 2005 Mar; 23(7):1548-54. PubMed ID: 15735130
[TBL] [Abstract][Full Text] [Related]
23. Improving colorectal cancer screening in a medical residents' primary care clinic.
Struewing JP; Pape DM; Snow DA
Am J Prev Med; 1991; 7(2):75-81. PubMed ID: 1910891
[TBL] [Abstract][Full Text] [Related]
24. Charlson Index is associated with one-year mortality in emergency department patients with suspected infection.
Murray SB; Bates DW; Ngo L; Ufberg JW; Shapiro NI
Acad Emerg Med; 2006 May; 13(5):530-6. PubMed ID: 16551775
[TBL] [Abstract][Full Text] [Related]
25. Trends in colorectal cancer testing among Medicare subpopulations.
Fenton JJ; Cai Y; Green P; Beckett LA; Franks P; Baldwin LM
Am J Prev Med; 2008 Sep; 35(3):194-202. PubMed ID: 18619761
[TBL] [Abstract][Full Text] [Related]
26. Influence of patient-provider communication on colorectal cancer screening.
Carcaise-Edinboro P; Bradley CJ
Med Care; 2008 Jul; 46(7):738-45. PubMed ID: 18580394
[TBL] [Abstract][Full Text] [Related]
27. Impact of comorbidity on survival of Danish prostate cancer patients, 1995-2006: a population-based cohort study.
Lund L; Borre M; Jacobsen J; Sørensen HT; Nørgaard M
Urology; 2008 Dec; 72(6):1258-62. PubMed ID: 18342917
[TBL] [Abstract][Full Text] [Related]
28. Increase in screening for colorectal cancer in older Americans: results from a national survey.
Chen X; White MC; Peipins LA; Seeff LC
J Am Geriatr Soc; 2008 Aug; 56(8):1511-6. PubMed ID: 18662217
[TBL] [Abstract][Full Text] [Related]
29. Communication and colorectal cancer screening among the uninsured: data from the Health Information National Trends Survey (United States).
Cairns CP; Viswanath K
Cancer Causes Control; 2006 Nov; 17(9):1115-25. PubMed ID: 17006717
[TBL] [Abstract][Full Text] [Related]
30. Institutional commitment to rectal cancer screening results in earlier-stage cancers on diagnosis.
Battat AC; Rouse RV; Dempsey L; Safadi BY; Wren SM
Ann Surg Oncol; 2004 Nov; 11(11):970-6. PubMed ID: 15525825
[TBL] [Abstract][Full Text] [Related]
31. Impact of age and comorbidity on colorectal cancer screening among older veterans.
Walter LC; Lindquist K; Nugent S; Schult T; Lee SJ; Casadei MA; Partin MR
Ann Intern Med; 2009 Apr; 150(7):465-73. PubMed ID: 19349631
[TBL] [Abstract][Full Text] [Related]
32. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
[TBL] [Abstract][Full Text] [Related]
33. Trends in colorectal cancer test use in the medicare population, 1998-2005.
Schenck AP; Peacock SC; Klabunde CN; Lapin P; Coan JF; Brown ML
Am J Prev Med; 2009 Jul; 37(1):1-7. PubMed ID: 19423273
[TBL] [Abstract][Full Text] [Related]
34. Suboptimal depression screening following cancer diagnosis.
Jones LE; Doebbeling CC
Gen Hosp Psychiatry; 2007; 29(6):547-54. PubMed ID: 18022048
[TBL] [Abstract][Full Text] [Related]
35. Timely follow-up of positive fecal occult blood tests strategies associated with improvement.
Powell AA; Gravely AA; Ordin DL; Schlosser JE; Partin MR
Am J Prev Med; 2009 Aug; 37(2):87-93. PubMed ID: 19524390
[TBL] [Abstract][Full Text] [Related]
36. Colonoscopy is the preferred colorectal cancer screening method in a population-based program.
Marbet UA; Bauerfeind P; Brunner J; Dorta G; Valloton JJ; Delcò F
Endoscopy; 2008 Aug; 40(8):650-5. PubMed ID: 18609465
[TBL] [Abstract][Full Text] [Related]
37. The place of fecal occult blood test in colorectal cancer screening in 2006: the U.S. perspective.
Bond JH
Am J Gastroenterol; 2006 Feb; 101(2):219-21. PubMed ID: 16454821
[No Abstract] [Full Text] [Related]
38. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer.
Lindholm E; Brevinge H; Haglind E
Br J Surg; 2008 Aug; 95(8):1029-36. PubMed ID: 18563785
[TBL] [Abstract][Full Text] [Related]
39. Potentially inappropriate prescribing for the elderly: effects of geriatric care at the patient and health care system level.
Pugh MJ; Rosen AK; Montez-Rath M; Amuan ME; Fincke BG; Burk M; Bierman A; Cunningham F; Mortensen EM; Berlowitz DR
Med Care; 2008 Feb; 46(2):167-73. PubMed ID: 18219245
[TBL] [Abstract][Full Text] [Related]
40. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
